131 related articles for article (PubMed ID: 38621326)
1. Addressing positive multi-cancer early detection tests in head and neck Surgery: Experience with head and neck work up for high-risk referrals.
Fearington FW; Zhao CY; Romero-Brufau S; Moore EJ; Price DL; Tasche KK; Yin LX; Kunkel ET; Kisiel JB; Giridhar KV; Routman DM; Van Abel KM
Oral Oncol; 2024 May; 152():106809. PubMed ID: 38621326
[TBL] [Abstract][Full Text] [Related]
2. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
[TBL] [Abstract][Full Text] [Related]
4. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.
Pynnonen MA; Gillespie MB; Roman B; Rosenfeld RM; Tunkel DE; Bontempo L; Brook I; Chick DA; Colandrea M; Finestone SA; Fowler JC; Griffith CC; Henson Z; Levine C; Mehta V; Salama A; Scharpf J; Shatzkes DR; Stern WB; Youngerman JS; Corrigan MD
Otolaryngol Head Neck Surg; 2017 Sep; 157(2_suppl):S1-S30. PubMed ID: 28891406
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
[TBL] [Abstract][Full Text] [Related]
6. The impact and prevalence of SARS-CoV-2 in patients with head and neck cancer and acute upper airway infection in a tertiary otorhinolaryngology referral center in Denmark.
Andersen PA; Rasmussen KMB; Channir HI; von Buchwald C; Cayé-Thomasen P; Klokker M; Knudsen JD; Kirkby NS; Aanaes K; Jensen RG
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3409-3415. PubMed ID: 33388982
[TBL] [Abstract][Full Text] [Related]
7. Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.
Gelhorn H; Ross MM; Kansal AR; Fung ET; Seiden MV; Krucien N; Chung KC
Patient; 2023 Jan; 16(1):43-56. PubMed ID: 35844011
[TBL] [Abstract][Full Text] [Related]
8. Outcome of two-week head and neck cancer pathway for the otolaryngology department in a tertiary centre.
Mettias B; Charlton A; Ashokkumar S
J Laryngol Otol; 2021 Oct; 135(10):869-873. PubMed ID: 34348805
[TBL] [Abstract][Full Text] [Related]
9. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
Schmeising-Barnes N; Waller J; Marlow LAV
Soc Sci Med; 2024 Apr; 347():116762. PubMed ID: 38520825
[TBL] [Abstract][Full Text] [Related]
10. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
11. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
[TBL] [Abstract][Full Text] [Related]
12. Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostaining.
El-Salem F; Mansour M; Gitman M; Miles BA; Posner MR; Bakst RL; Genden EM; Westra WH
Oral Oncol; 2019 Mar; 90():74-79. PubMed ID: 30846180
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
[TBL] [Abstract][Full Text] [Related]
14. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
Bishop JA; Lewis JS; Rocco JW; Faquin WC
Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
[TBL] [Abstract][Full Text] [Related]
15. The 2-week rule for suspected head and neck cancer in the United Kingdom: referral patterns, diagnostic efficacy of the guidelines and compliance.
McKie C; Ahmad UA; Fellows S; Meikle D; Stafford FW; Thomson PJ; Welch AR; Paleri V
Oral Oncol; 2008 Sep; 44(9):851-6. PubMed ID: 18234546
[TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
[TBL] [Abstract][Full Text] [Related]
19. Refining the head and neck cancer referral guidelines: a two-centre analysis of 4715 referrals.
Tikka T; Pracy P; Paleri V
Clin Otolaryngol; 2016 Feb; 41(1):66-75. PubMed ID: 26611658
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of head and neck cancer patients referred to an oral and maxillofacial surgeon in the United States for management.
Holmes JD; Martin RA; Gutta R
J Oral Maxillofac Surg; 2010 Mar; 68(3):555-61. PubMed ID: 20171475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
